Jennifer Perry (Siverling)

Jennifer (Siverling) Perry has extensive work experience in the pharmaceutical industry, with a focus on quality and compliance. Currently, they hold the position of Associate Vice President, Quality and Compliance at Aurobindo Pharma USA, Inc. since September 2021. Prior to this role, they served as the Director, Quality and Compliance (Site Head of Quality) at the same company starting in September 2019.

Before joining Aurobindo Pharma, Jennifer was the Corporate Head of DEA Compliance at Pentec Health from November 2016 to September 2019. Jennifer also worked at SUN PHARMA as an Associate Director, DEA and State Licensing Compliance from December 2015 to November 2016.

Jennifer began their pharmaceutical career at Aurobindo Pharma USA, Inc., where they held the positions of DEA Compliance Manager from October 2014 to December 2015, and DEA Coordinator from December 2012 to November 2014.

Prior to joining Aurobindo Pharma, they worked as a Chemist-Research and Development at Aurolife Pharma from August 2010 to December 2012, and as an Analytical Development Support Chemist at Schwarz Pharma from August 2009 to September 2010.

Additionally, Jennifer gained experience at the US EPA as a Graduate Student Trainee from October 2007 to June 2009, and at the University of Cincinnati as a Teaching Assistant from September 2006 to November 2007.

Jennifer (Siverling) Perry obtained a Bachelor of Science degree in Chemistry from Ohio University, where they studied from 2002 to 2006. Jennifer later pursued a Master of Science degree in Chemistry from the University of Cincinnati from 2006 to 2009.